About Vensun Pharmaceuticals
Vensun Pharmaceuticals is a Healthcare company based in Yardley (United States) founded in 2011, and was acquired by Strides Pharma Science in January 2019. Generic prescription pharmaceuticals are developed and distributed in various forms. Vensun Pharmaceuticals has raised $45.69 million across 5 funding rounds from investors including Strides Pharma Science, Perceptive Advisors and Deerfield. The company has 18 employees. Vensun Pharmaceuticals offers products and services including Generic Prescription Drugs and ANDA Products. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Vensun Pharmaceuticals, Inc.
Company details
Founded in 2011, Vensun Pharmaceuticals operates in the generic drug sector from Yardley, United States. A portfolio of prescription products is developed across multiple dosage forms and therapeutic categories. Exclusive distribution rights are held for approved items, while others await FDA approval. In-licensing opportunities are pursued, and products from partners are marketed. Focus remains on generic pharmaceutical development and distribution.
- Headquarters Yardley, United States
- Employees 18
- Stage Acquired
- SectorsHealthcare
- Website vensunrx.com
- Social LinkedIn
- Acquired by Strides Pharma Science (Jan 2019)
- Legal Name Vensun Pharmaceuticals, Inc
- Total Equity Funding$45.69M (USD)
in 5 rounds
- Latest Funding Round$22.5M (USD), Series C
Dec 2016
- InvestorsStrides Pharma Science
& 4 more
- Employee Count18
- Acquired byStrides Pharma Science
(Jan 2019)
Products & Services of Vensun Pharmaceuticals
Vensun Pharmaceuticals offers a comprehensive portfolio of products and services, including Generic Prescription Drugs and ANDA Products.
Generic prescription products are developed and distributed across various therapeutic categories.
Exclusive distribution rights are maintained for approved ANDA products and those pending FDA approval.
Funding Insights of Vensun Pharmaceuticals
Vensun Pharmaceuticals has successfully raised a total of $45.69M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $22.5 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $45.69M
- Total Rounds 5
- Last Round Series C — $22.5M
- First Round $1.68M
(Oct 2011)
- Investors Count 4
All 5 funding rounds of Vensun Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2016 | $22.5M | Series C | – | Perceptive Advisors, Deerfield | |
| Sep 2015 | $4M | Debt – Conventional | – | – | – |
| Oct 2013 | $15.8M | Series B | – | JW Asset Management | |
| Mar 2012 | $5.71M | Series A | – | – | |
| Oct 2011 | $1.68M | Seed | – | – | – |
5 investors in total: 4 institutional and 1 angel.
Investors in Vensun Pharmaceuticals
Vensun Pharmaceuticals has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Strides Pharma Science, Perceptive Advisors and Deerfield.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health-tech companies are targeted for venture capital investments. | 1999 | perceptivelife.com | New York, United States | |
Healthcare ecosystem is supported through investment and innovation by Deerfield. | deerfield.com | New York, United States | ||
Investment services are offered in healthcare and cannabis sectors. | jwfunds.com | |||
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | strides.com | Bengaluru, India | |
AC Allen Chao | Indian angel investor, active in early-stage startups, focus on tech and innovation. | unknown_5e8802298d9143dcb |
Investor details for Vensun Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Vensun Pharmaceuticals
4 dated milestones of Vensun Pharmaceuticals across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Vensun Pharmaceuticals is founded.
- Funding First funding round of $1.7M.
- Funding Latest funding round, Series C, of $22.5M.
- Exit Acquired by Strides Pharma Science.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Vensun Pharmaceuticals (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vensun Pharmaceuticals
Complete news archive for Vensun Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vensun Pharmaceuticals
Vensun Pharmaceuticals was founded in 2011.
Vensun Pharmaceuticals is headquartered in Yardley, United States. It is registered at Yardley, Pennsylvania, United States.
Vensun Pharmaceuticals is a funded company, having raised a total of $45.69M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.68M, raised on Oct 2011.
Vensun Pharmaceuticals has 18 employees.
Founded in 2011, Vensun Pharmaceuticals operates in the generic drug sector from Yardley, United States. A portfolio of prescription products is developed across multiple dosage forms and therapeutic categories. Exclusive distribution rights are held for approved items, while others await FDA approval. In-licensing opportunities are pursued, and products from partners are marketed. Focus remains on generic pharmaceutical development and distribution.
Vensun Pharmaceuticals offers Generic Prescription Drugs and ANDA Products.
Vensun Pharmaceuticals has 5 investors. Key investors include Strides Pharma Science, Perceptive Advisors, Deerfield, Allen Chao, and JW Asset Management.
Vensun Pharmaceuticals operates through Vensun Pharmaceuticals, Inc.
Yes. Vensun Pharmaceuticals was acquired by Strides Pharma Science in January 2019.